Northwestern University
Dr. VanderWeele is an Associate Professor in Medicine - Hematology/Oncology. He specializes in the treatment of genitourinary (GU) cancer from a medical oncology perspective. His research efforts have focused especially on altering the course of potentially lethal GU cancers using targeted therapies. He did his medical and research training at the University of Chicago, where he developed a research program characterizing the heterogeneity and evolution of the cancer genome. He moved to the National Cancer Institute where he continued to seek to improve the treatment of prostate cancer based on patients’ genome-based therapeutic vulnerabilities. He returned to Chicago in 2018 to join the GU cancer team at Northwestern University, where he continues to translate discoveries made at the bench into improved therapies in the clinic. He practices in the GU clinic and is the GU lead in the Early Phase Therapeutics clinic. He is the principle investigator for multiple biomarker-selected studies for newly diagnosed prostate cancer. He is active in the Alliance and SWOG cooperative groups, where he is on the leadership teams of multiple phase III studies. He collaborates with basic and translational scientists to develop tissue and liquid biomarkers to identify and characterize aggressive disease, and he is the Interim Director of the OncoSET Precision Oncology Program. In the clinic Dr. VanderWeele sees patients with prostate, bladder, or testicular cancer.
Astellas (Individual(s) Involved: Self; Clinical Condition: Prostate cancer): I gave an ASCO review for an educational group which Astellas gave some financial support, Other Financial or Material Support; Janssen, (Individual(s) Involved: Self; Clinical Condition: Prostate cancer): Advisory Board
Friday, September 30, 2022
12:59 PM – 1:05 PM
Friday, September 30, 2022
1:19 PM – 1:25 PM
Friday, September 30, 2022
1:25 PM – 1:45 PM
Friday, September 30, 2022
1:52 PM – 1:59 PM
Friday, September 30, 2022
1:59 PM – 2:05 PM
Friday, September 30, 2022
2:05 PM – 2:30 PM
Friday, September 30, 2022
12:10 PM – 2:30 PM